GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: May 7, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | May 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-repurchase, company-announcement
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on May 7, 2025, that it purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount of the transaction.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine disclosure of share repurchases, which is common for publicly traded companies.
Key Players & Entities
- GSK plc (company) — The company making the share purchase.
- Citigroup Global Markets Limited (company) — The corporate stockbroker acting on behalf of GSK plc.
- May 7, 2025 (date) — The date of the announcement and purchase.
FAQ
What was the specific number of GSK plc ordinary shares purchased?
The filing states that a 'number' of ordinary shares were purchased but does not specify the exact quantity.
What was the total dollar amount spent on the share repurchase?
The filing does not disclose the total dollar amount of the share repurchase.
Through which entity did GSK plc conduct these share purchases?
GSK plc acted through its corporate stockbroker, Citigroup Global Markets Limited.
What is the par value of GSK plc's ordinary shares?
The ordinary shares have a par value of 31 1/4 pence each.
Is this a new share repurchase program or a continuation?
The filing indicates a 'Transaction in own shares' and does not provide details on whether it's a new or ongoing program.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 7, 2025 regarding GSK plc (GLAXF).